| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93f530462e7d08cc5f62a0aff71f0be4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b327b7817e09c3837a2c00c6e618e81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd80fd0b40dc6c6b665a330bb4e17bf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e1018b924ad1e238642eaad9d2172a7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70503
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1093 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-10 |
| filingDate |
2011-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8c4a9a7d8ff728337b816ab1bfc541c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d84a9d71860015af53a8a8e84a543e73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_841e31c2789944e4448b1d69b8903437 |
| publicationDate |
2013-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013272958-A1 |
| titleOfInvention |
Anti-ceacam6 antibodies and uses thereof |
| abstract |
The present invention relates to isolated or purified antibodies or fragments thereof specific for CEACAM6 and their use as therapeutic or diagnostic tools. Specifically, the present invention is directed to antibodies or fragments thereof specific for a linear epitope of CEACAM6. In vivo and in vitro methods of diagnosis as well as therapeutic methods are also described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11623953-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109477114-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018157169-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021178951-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11702466-B2 |
| priorityDate |
2010-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |